Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary L Disis

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Human Immunology|June 20, 2002
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patientKeith L Knutson, Mary L Disis
Omics : a Journal of Integrative Biology|July 8, 2011
Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptMegan M O'Meara, Mary L Disis
Breast (Edinburgh, Scotland)|February 7, 2017
Immunotherapy in breast cancer: An introductionMary L Disis, Sasha E Stanton
The Journal of Clinical Investigation|March 3, 2004
Immune system versus tumor: shifting the balance in favor of DCs and effective immunityHoward L Kaufman, Mary L Disis
Frontiers in Immunology|February 13, 2025
Vaccines for cancer interception in familial adenomatous polyposisDavid E Johnson, Mary L Disis
Breast Cancer Research and Treatment|November 30, 2021
Breast cancer vaccines for treatment and preventionMary L Disis, Denise L Cecil
Journal of Translational Medicine|August 11, 2004
Conflicts of interest in translational researchMalcolm R Parks, Mary L Disis
Cancer Research and Treatment|October 8, 2009
Immunomodulation of breast cancer via tumor antigen specific Th1Mary L Disis, Kyong Hwa Park
Journal for Immunotherapy of Cancer|October 26, 2016
Clinical significance of tumor-infiltrating lymphocytes in breast cancerSasha E Stanton, Mary L Disis
Clinical Lung Cancer|June 11, 2008
Immune modulation as a therapeutic strategy for non-small-cell lung cancerGregory E Holt, Mary L Disis
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Human Immunology|June 20, 2002
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patientKeith L Knutson, Mary L Disis
Omics : a Journal of Integrative Biology|July 8, 2011
Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptMegan M O'Meara, Mary L Disis
Breast (Edinburgh, Scotland)|February 7, 2017
Immunotherapy in breast cancer: An introductionMary L Disis, Sasha E Stanton
The Journal of Clinical Investigation|March 3, 2004
Immune system versus tumor: shifting the balance in favor of DCs and effective immunityHoward L Kaufman, Mary L Disis
Frontiers in Immunology|February 13, 2025
Vaccines for cancer interception in familial adenomatous polyposisDavid E Johnson, Mary L Disis
Breast Cancer Research and Treatment|November 30, 2021
Breast cancer vaccines for treatment and preventionMary L Disis, Denise L Cecil
Journal of Translational Medicine|August 11, 2004
Conflicts of interest in translational researchMalcolm R Parks, Mary L Disis
Cancer Research and Treatment|October 8, 2009
Immunomodulation of breast cancer via tumor antigen specific Th1Mary L Disis, Kyong Hwa Park
Journal for Immunotherapy of Cancer|October 26, 2016
Clinical significance of tumor-infiltrating lymphocytes in breast cancerSasha E Stanton, Mary L Disis
Clinical Lung Cancer|June 11, 2008
Immune modulation as a therapeutic strategy for non-small-cell lung cancerGregory E Holt, Mary L Disis
Pageof 19